Gerry Smith

Gerry Smith

Gerry Smith is a biotech reporter for Bloomberg News in New York.

Latest

Trump Administration To Attempt To Slash Prescription Drug Prices

RevMed’s Cancer Drug Nearly Doubles Overall Survival in Pivotal Study

April 13, 2026

April 13, 2026

RevMed’s Cancer Drug Nearly Doubles Overall Survival in Pivotal Study

Trump Administration To Attempt To Slash Prescription Drug Prices

April 10, 2026

April 10, 2026

Replimune Plunges After FDA Rejects Skin Cancer Drug Again

FDA Chief Says He Wants Gene Therapy Head Prasad to Return

April 9, 2026

April 9, 2026

FDA Withdraws GSK’s Approval of Drug Touted as Autism Treatment

GSK Plc Workers Strike In A Pay Dispute

April 6, 2026

April 6, 2026

Neurocrine to Buy Soleno Therapeutics for $2.9 Billion

Traders At The New York Stock Exchange As Stocks Fall As Oil Surge Boosts Treasury Yields

March 31, 2026

March 31, 2026

Biogen Buys Apellis for $5.6 Billion to Expand Kidney Drugs

Biogen to Buy Apellis for $5.6 Billion to Boost Kidney Franchise

March 30, 2026

March 30, 2026

Biogen Wins FDA Approval for High-Dose Version of Spinraza

March 26, 2026

March 26, 2026

Nucleus Genomics Expands ‘Optimization’ Embryo Testing to India, Middle East

Inside Genesis Greece's Biggest Fertility Clinic

March 26, 2026

March 26, 2026

Wave Plunges More Than 50% After Obesity Shot Falls Short

A weight loss injection pen.

March 19, 2026

March 19, 2026

Trump Medicare Chief Says Private Plans Not Controlling Costs

Lilly, Novo To Lower Obesity Drug Prices In Deal With Trump

March 12, 2026

March 12, 2026

Obesity Drugmaker Zealand Plans New Boston Research Hub

Coronavirus Pandemic Causes Climate Of Anxiety And Changing Routines In America

March 10, 2026

March 10, 2026

US Senator Investigates FDA Over Rare-Disease Drug Denials

Senate Republicans Advance Trump Tax Bill On Crucial Test Vote

March 9, 2026

March 9, 2026

Vertex Rises as Kidney Drug Meets Goal in Late-Stage Trial

Vertex Pharma To Get Investment From Cystic Fibrosis Foundation

March 6, 2026

March 6, 2026

FDA Vaccine Chief Vinay Prasad Set to Leave Post Next Month

Vinay Prasad

March 4, 2026

March 4, 2026

FDA Push for Fake Brain Surgery Trial Spurs Ethical Concerns

FDA

March 3, 2026

March 3, 2026

Moderna to Pay About $1 Billion to Settle Arbutus Litigation

Moderna's First Vaccine Was a Big Hit. Its Second Is a Let Down

March 2, 2026

March 2, 2026

UniQure Falls as FDA Seeks Controversial Gene Therapy Study

February 27, 2026

February 27, 2026

Moderna Wins EU Nod for Covid-Flu Combo Shot Stalled in US

Moderna's First Vaccine Was a Big Hit. Its Second Is a Let Down

February 13, 2026

February 13, 2026

Moderna Blames FDA for Threatening US Leadership in Medicine

Moderna's First Vaccine Was a Big Hit. Its Second Is a Let Down

February 12, 2026

February 12, 2026

Moderna’s Flu Vaccine Stalls at FDA Despite Need for Better Shot

Regulatory requirements change as anti-vaccine movement grows

Moderna's First Vaccine Was a Big Hit. Its Second Is a Let Down

February 10, 2026

February 10, 2026

FDA Refuses to Review Moderna Flu Shot in Surprise Setback

Moderna's First Vaccine Was a Big Hit. Its Second Is a Let Down